Treanda 25 mg (Bendamustine Hydrochloride POWDER FOR SOLUTION) 25 MG

TREANDA 25 MG is a powder for solution containing bendamustine hydrochloride, used for certain medical conditions. This intravenous medication is manufactured by Teva Canada Limited.

Strength

25 MG

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TREANDA 25 MG is a medication that contains bendamustine hydrochloride, a chemotherapy agent. It is commonly used in the treatment of certain types of cancer, such as chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma. The primary use of bendamustine is to target and destroy cancer cells, helping to manage and control the progression of these diseases. Patients often wonder what TREANDA 25 MG is used for, and it is typically prescribed by healthcare professionals for these specific indications.

Side Effects

When administered intravenously, TREANDA 25 MG may cause common side effects such as nausea, fatigue, and low blood cell counts. Some patients may also experience vomiting, fever, and infections. These effects can vary from person to person, and it is important to discuss any concerns with a healthcare provider.

Precautions & Warnings

TREANDA 25 MG should be handled with care and administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration instructions to minimize the risk of side effects. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment with TREANDA 25 MG.

Avoid Interactions

TREANDA 25 MG may interact with other medications, including those that suppress the immune system or affect blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol and certain foods may also interact with TREANDA 25 MG, so it is advisable to discuss these factors with your healthcare provider.

Frequently Asked Questions

TREANDA 25 MG is used in the treatment of certain types of cancer, such as chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma.

TREANDA 25 MG is administered intravenously as a powder for solution.

Common side effects may include nausea, fatigue, low blood cell counts, vomiting, fever, and infections.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

TREANDA 25 MG is manufactured by Teva Canada Limited.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.